Thermo Fisher Scientific Inc (TMO) - Total Assets
Based on the latest financial reports, Thermo Fisher Scientific Inc (TMO) holds total assets worth $103.02 Billion USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore TMO cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Thermo Fisher Scientific Inc - Total Assets Trend (1985–2024)
This chart illustrates how Thermo Fisher Scientific Inc's total assets have evolved over time, based on quarterly financial data. See Thermo Fisher Scientific Inc (TMO) net assets for net asset value and shareholders' equity analysis.
Thermo Fisher Scientific Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Thermo Fisher Scientific Inc's total assets of $103.02 Billion consist of 22.8% current assets and 77.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $4.01 Billion | 4.1% |
| Accounts Receivable | $9.63 Billion | 9.9% |
| Inventory | $4.98 Billion | 5.1% |
| Property, Plant & Equipment | $10.79 Billion | 11.1% |
| Intangible Assets | $15.53 Billion | 16.0% |
| Goodwill | $45.85 Billion | 47.1% |
Asset Composition Trend (1985–2024)
This chart illustrates how Thermo Fisher Scientific Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Thermo Fisher Scientific Inc worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Thermo Fisher Scientific Inc's current assets represent 22.8% of total assets in 2024, a decrease from 59.3% in 1985.
- Cash Position: Cash and equivalents constituted 4.1% of total assets in 2024, down from 13.5% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 62.0% of total assets, an increase from 13.0% in 1985.
- Asset Diversification: The largest asset category is goodwill at 47.1% of total assets.
Thermo Fisher Scientific Inc Competitors by Total Assets
Key competitors of Thermo Fisher Scientific Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
Cowealth Medical China Co.Ltd.
SHG:603122
|
China | CN¥1.41 Billion |
|
Prodia Widyahusada Tbk PT
JK:PRDA
|
Indonesia | Rp2.57 Trillion |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
Thermo Fisher Scientific Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.50 | 1.63 | 2.13 |
| Quick Ratio | 1.11 | 1.26 | 1.74 |
| Cash Ratio | 0.00 | 0.32 | 0.00 |
| Working Capital | $7.41 Billion | $9.18 Billion | $11.65 Billion |
Thermo Fisher Scientific Inc - Advanced Valuation Insights
This section examines the relationship between Thermo Fisher Scientific Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.32 |
| Latest Market Cap to Assets Ratio | 2.22 |
| Asset Growth Rate (YoY) | -1.4% |
| Total Assets | $97.32 Billion |
| Market Capitalization | $215.77 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Thermo Fisher Scientific Inc's assets at a significant premium (2.22x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: Thermo Fisher Scientific Inc's assets decreased by 1.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Thermo Fisher Scientific Inc (1985–2024)
The table below shows the annual total assets of Thermo Fisher Scientific Inc from 1985 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $97.32 Billion | -1.42% |
| 2023-12-31 | $98.73 Billion | +1.62% |
| 2022-12-31 | $97.15 Billion | +2.14% |
| 2021-12-31 | $95.12 Billion | +37.76% |
| 2020-12-31 | $69.05 Billion | +18.28% |
| 2019-12-31 | $58.38 Billion | +3.82% |
| 2018-12-31 | $56.23 Billion | -0.77% |
| 2017-12-31 | $56.67 Billion | +23.44% |
| 2016-12-31 | $45.91 Billion | +12.43% |
| 2015-12-31 | $40.83 Billion | -4.71% |
| 2014-12-31 | $42.85 Billion | +34.49% |
| 2013-12-31 | $31.86 Billion | +16.10% |
| 2012-12-31 | $27.44 Billion | +2.28% |
| 2011-12-31 | $26.83 Billion | +25.47% |
| 2010-12-31 | $21.39 Billion | -0.99% |
| 2009-12-31 | $21.60 Billion | +2.42% |
| 2008-12-31 | $21.09 Billion | -0.55% |
| 2007-12-31 | $21.21 Billion | -0.26% |
| 2006-12-31 | $21.26 Billion | +400.10% |
| 2005-12-31 | $4.25 Billion | +18.87% |
| 2004-12-31 | $3.58 Billion | +5.54% |
| 2003-12-31 | $3.39 Billion | -7.08% |
| 2002-12-31 | $3.65 Billion | -4.65% |
| 2001-12-31 | $3.83 Billion | -21.34% |
| 2000-12-31 | $4.86 Billion | -6.15% |
| 1999-12-31 | $5.18 Billion | -18.16% |
| 1998-12-31 | $6.33 Billion | +9.24% |
| 1997-12-31 | $5.80 Billion | +12.73% |
| 1996-12-31 | $5.14 Billion | +37.29% |
| 1995-12-31 | $3.74 Billion | +24.01% |
| 1994-12-31 | $3.02 Billion | +22.08% |
| 1993-12-31 | $2.47 Billion | +36.04% |
| 1992-12-31 | $1.82 Billion | +51.59% |
| 1991-12-31 | $1.20 Billion | +33.54% |
| 1990-12-31 | $898.20 Million | +44.03% |
| 1989-12-31 | $623.60 Million | +27.24% |
| 1988-12-31 | $490.10 Million | +15.02% |
| 1987-12-31 | $426.10 Million | +37.94% |
| 1986-12-31 | $308.90 Million | +39.33% |
| 1985-12-31 | $221.70 Million | -- |
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines,… Read more